Edwards syndrome (Trisomy 18)
Edwards syndrome, or trisomy 18, is a chromosomal condition caused by an extra chromosome 18. It produces multiple congenital anomalies, serious developmental impairment, and a low survival rate.
Edwards syndrome, commonly called trisomy 18, is a chromosomal condition in which an individual has three copies of chromosome 18 instead of the usual two. This extra genetic material interferes with normal development and causes a recognizable pattern of physical and intellectual disabilities. The disorder is named after John H. Edwards, who described the syndrome in 1960. It is one of the autosomal trisomies that can persist to live birth and is second in frequency to Down syndrome among those that do.
Image gallery
3 ImagesKey features
The clinical presentation of Edwards syndrome is variable but tends to be severe. Frequently observed findings include:
- Low birth weight and poor growth before and after birth.
- Craniofacial differences such as a small jaw (micrognathia), low-set ears, and a small head (microcephaly).
- Cardiac malformations, which are common and a major determinant of outcome.
- Kidney and urinary tract abnormalities and other internal organ malformations.
- Limbs with characteristic positioning: clenched hands with overlapping fingers and rocker-bottom feet.
- Significant intellectual disability and developmental delay in survivors.
Cause, types, and diagnosis
The underlying cause is a chromosomal aneuploidy: three copies of chromosome 18. Most cases are due to nondisjunction during gamete formation (full trisomy 18), but some result from chromosomal translocations or from mosaic patterns in which only a portion of cells carry the extra chromosome. Mosaic cases are often milder.
Diagnosis can be made prenatally or after birth. Prenatal screening approaches include maternal serum screening and detailed ultrasound examinations that may detect growth restriction or structural anomalies. Definitive diagnosis uses chromosome analysis from chorionic villus sampling, amniocentesis, or postnatal karyotyping. Molecular techniques such as microarray testing can identify partial duplications and complex rearrangements.
Prognosis and management
Edwards syndrome carries a high risk of pregnancy loss and early infant mortality. Many affected fetuses miscarry or are stillborn, and among live births survival is limited: a substantial proportion die within the first weeks of life. Estimates of survival vary by study, and severity is strongly influenced by the presence and extent of organ malformations and by whether the trisomy is mosaic or complete. Discussions of life expectancy should therefore be individualized.
Management focuses on symptomatic and supportive care. This may include feeding support, management of cardiac or respiratory problems, and treatment of other organ-specific issues. In some cases surgical interventions are considered, but decisions are complex and require multidisciplinary counseling that balances expected benefits, risks, and quality-of-life considerations. Palliative care is an important component of planning for infants with severe manifestations.
History, epidemiology, and notable distinctions
Edwards syndrome was characterized in the medical literature in 1960. Birth incidence among live-born infants has commonly been cited in the range of about one in several thousand births; the likelihood of a trisomy 18 conception and of a pregnancy carrying to term both increase with advancing maternal age. The condition is distinct from other trisomies in its typical pattern of malformations and its generally more severe prognosis compared with, for example, trisomy 21 (Down syndrome).
Because outcomes vary and ethical issues are central to care, families benefit from clear, up-to-date genetic counseling and access to a coordinated clinical team. Ongoing research into long-term outcomes, management strategies, and supportive treatments aims to improve understanding and care for affected children and their families.
For further clinical summaries and resources, see professional genetic and pediatric resources via genetic disorder overviews and specialist guidance available through clinical genetics centers and patient support organizations.
Questions and answers
Q: What is Trisomy 18?
A: Trisomy 18, also known as Edwards syndrome, is a genetic disorder where affected individuals have three copies of chromosome 18 instead of the normal two copies.
Q: Who is John H. Edwards?
A: John H. Edwards is the person after whom Trisomy 18 is named. He first described the syndrome in 1960.
Q: How common is Trisomy 18?
A: Trisomy 18 affects about one in 3,000 live births.
Q: What are some common health complications associated with Trisomy 18?
A: People with Trisomy 18 often have heart abnormalities, kidney malformations, and other internal organ disorders.
Q: What is the survival rate of babies with Trisomy 18?
A: About 95% of babies with Trisomy 18 die before they are born. About half of all babies born with the condition will reach two months of age, and only 5-10% will survive for a year. The median life span is five to fifteen days.
Q: What proportion of children born with Trisomy 18 live to age ten?
A: One percent of children born with Trisomy 18 live to age ten, typically in cases of the less severe mosaic Edwards syndrome.
Q: Does the incidence of Trisomy 18 increase with the mother's age?
A: Yes, the incidence of Trisomy 18 increases as the mother's age increases.
Related articles
Author
AlegsaOnline.com Edwards syndrome (Trisomy 18) Leandro Alegsa
URL: https://en.alegsaonline.com/art/30307
Sources
- whonamedit.com : "Edwards syndrome (John Hilton Edwards)"
- nlm.nih.gov : nlm.nih.gov/MEDLINEPLUS/ency/article/001661.htm
- books.google.com : Fetal Medicine: Basic Science and Clinical Practice
- findarticles.com : findarticles.com
- emedicine.com : "Introduction to Trisomy 18"